A Prospective Clinical Trial of Radiation Therapy for Dupuytren's Contracture Following Surgical and Non-Surgical Release

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are: • Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum? Participants will undergo: * Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection * Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: t
View:

• Age 45 or greater with DC

• Extension deficit \>10 degrees

• Unable to simultaneously place the affected finger and palm flat on a table.

• Women included in the study will be post-menopausal or using contraception, and a pregnancy test will be performed as standard of care.

• For patients who are having multiple CCH injections, only the first 2 joints on given hand will be included

Locations
United States
New Hampshire
Dartmouth Hitchcock
RECRUITING
Lebanon
Contact Information
Primary
Julia S Schwarz, MD
julia.s.schwarz@hitchcock.org
603 650-5133
Backup
Lance Warhold, MD
603 650-5133
Time Frame
Start Date: 2024-09-16
Estimated Completion Date: 2032-04
Participants
Target number of participants: 95
Treatments
Experimental: Patients with Dupuytren's Contacture
Patients with Dupuytren's Contacture will undergo Collagenase Clostridium Histolyticum injection and release followed by two 5-day courses of radiation therapy separated by 6-8 weeks. They will then be followed for 3 years for recurrence.
Related Therapeutic Areas
Sponsors
Leads: Dartmouth-Hitchcock Medical Center

This content was sourced from clinicaltrials.gov